Tricky Profit
  • Stock
  • Economy
  • Politics
  • Editor’s Pick
Stock

Sanofi shares slide as FDA delays MS drug decision and late-stage trial disappoints

by December 15, 2025
by December 15, 2025 0 comment

The post Sanofi shares slide as FDA delays MS drug decision and late-stage trial disappoints appeared first on Invezz

0 comment
0
FacebookTwitterPinterestEmail

previous post
Silver volatility to continue in 2026; ING Group sees prices averaging $55/oz
next post
Here’s why this FTSE 100 Index stock jumped ~380% in 2025

You may also like

AI stocks fuel Nikkei 225 Index gains as...

December 22, 2025

Morning brief: Asian shares advance as Yen slides;...

December 22, 2025

Will the WPP share price rebound after the...

December 22, 2025

Rheinmetall share price forms alarming pattern: will it...

December 22, 2025

Baidu to bring robotaxi services to London via...

December 22, 2025

Weak labour market, not inflation, will drive multiple...

December 21, 2025

Palo Alto Networks stock: does Google Cloud deal...

December 20, 2025

CoreWeave stock soars on DOE news and analyst...

December 20, 2025

Europe bulletin: UK borrowing eases, France budget deadlock...

December 20, 2025

Brazil’s Ibovespa gains on Blue-Chip strength amid budget...

December 20, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • India–New Zealand free trade deal sealed as New Delhi pushes global trade ties

      December 22, 2025
    • How India’s strong economic growth is leaving its middle class behind

      December 22, 2025
    • Why gold, silver prices soared to record highs on Monday

      December 22, 2025
    • Solana price prediction: at risk despite rising transactions, ETF inflows

      December 22, 2025
    • Here’s why Hong Kong is rethinking how insurers invest in crypto and infrastructure

      December 22, 2025

    Disclaimer: TrickyProfit.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Copyright © 2025 TrickyProfit.com All Rights Reserved.

    Tricky Profit
    • Stock
    • Economy
    • Politics
    • Editor’s Pick